Targeted Drug Plus Hormone Therapy Stops Tumor Growth In Patients With Early Breast Cancer [Forbes]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Forbes
A targeted drug added to hormone therapy has shown promising results in the treatment of women with newly-diagnosed breast cancer. Photo credit: Getty Royalty Free. Getty A new clinical trial conducted in patients in the U.S., U.K., and Canada has shown that the addition of a targeted therapy drug to existing hormone treatment, greatly slows cancer cell growth in women with early-stage breast cancer. We have demonstrated that the current standard of care for many women – hormone treatment – is effective at stopping the growth of tumor cells prior to surgery, however with the addition of this new drug palbociclib patients may benefit even further, said Stephen Johnston, Medical Oncologist, Chief Investigator of the study and Professor of Breast Cancer Medicine at The Institute of Cancer Research in London, U.K. The drug, palbociclib, also known as IBRANCE in the U.S., has already shown good results in women with advanced breast cancer, but this trial show
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Morningstar unveils 10 cheap stocks with big moats [Yahoo! Finance]Yahoo! Finance
- Cramer's Lightning Round: Leidos is a winner [CNBC]CNBC
- United States Frontotemporal Dementia Market to Experience Steady Growth Through 2028 [Yahoo! Finance]Yahoo! Finance
- Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Pfizer, Astellas first-line bladder cancer therapy accepted for review in China [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 3/28/24 - Form DEFA14A
- 3/28/24 - Form DEFA14A
- 3/18/24 - Form 4
- PFE's page on the SEC website